{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:34:15Z","timestamp":1790408055357,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["302879\/2017-0"],"award-info":[{"award-number":["302879\/2017-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"crossref","award":["17\/2551-0000970-3"],"award-info":[{"award-number":["17\/2551-0000970-3"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["19\/2551-0001783-9"],"award-info":[{"award-number":["19\/2551-0001783-9"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004933","name":"Instituto Nacional de Ci\u00eancia e Tecnologia","doi-asserted-by":"crossref","award":["465671\/2014-4"],"award-info":[{"award-number":["465671\/2014-4"]}],"id":[{"id":"10.13039\/501100004933","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2016-05867"],"award-info":[{"award-number":["RGPIN-2016-05867"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11302-021-09775-w","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T18:02:41Z","timestamp":1616263361000},"page":"273-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Influence of NSAIDs and methotrexate on CD73 expression and glioma cell growth"],"prefix":"10.1007","volume":"17","author":[{"given":"Daniela Vasconcelos","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"de Fraga Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Fernando Lopes","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliete Nathali","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"S\u00e9vigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria Oliveira","family":"Battastini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabr\u00edcio","family":"Figueir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,20]]},"reference":[{"issue":"1","key":"9775_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"key":"9775_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-12-802997-8.00005-0","volume":"134","author":"A Perry","year":"2016","unstructured":"Perry A, Wesseling P (2016) Histologic classification of gliomas. Handb Clin Neurol 134:71\u201395. https:\/\/doi.org\/10.1016\/B978-0-12-802997-8.00005-0","journal-title":"Handb Clin Neurol"},{"key":"9775_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM (2012) Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment. Cancer Cell 21:309\u2013322. https:\/\/doi.org\/10.1016\/j.ccr.2012.02.022","journal-title":"Cancer Cell"},{"issue":"6","key":"9775_CR4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00401-015-1432-1","volume":"129","author":"K Aldape","year":"2015","unstructured":"Aldape K, Zadeh G, Mansouri S, Reifenberger G, von Deimling A (2015) Glioblastoma: pathology, molecular mechanisms and markers. Acta Neuropathol 129(6):829\u2013848. https:\/\/doi.org\/. https:\/\/doi.org\/10.1007\/s00401-015-1432-1","journal-title":"Acta Neuropathol"},{"issue":"45","key":"9775_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3238\/arztebl.2010.0799","volume":"107","author":"T Schneider","year":"2010","unstructured":"Schneider T, Mawrin C, Scherlach C, Skalej M, Firsching R (2010) Gliomas in adults. Dtsch Arztebl Int 107(45):799\u2013807; quiz 808. https:\/\/doi.org\/10.3238\/arztebl.2010.0799","journal-title":"Dtsch Arztebl Int"},{"key":"9775_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01526","volume":"8","author":"PA Mello","year":"2017","unstructured":"Mello PA, Coutinho-Silva R, Savio LEB (2017) Multifaceted effects of extracellular adenosine triphosphate and adenosine in the tumor-host interaction and therapeutic perspectives. Front Immunol 8:1\u201317. https:\/\/doi.org\/10.3389\/fimmu.2017.01526","journal-title":"Front Immunol"},{"issue":"14","key":"9775_CR7","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/onc.2012.269","volume":"32","author":"J Bastid","year":"2012","unstructured":"Bastid J, Cottalorda-Regairaz A, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A (2012) ENTPD1\/CD39 is a promising therapeutic target in oncology. Oncogene 32(14):1743\u20131751. https:\/\/doi.org\/10.1038\/onc.2012.269","journal-title":"Oncogene"},{"issue":"4","key":"9775_CR8","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino G, Kleinewietfeld M, Di Mitri D et al (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110(4):1225\u20131232. https:\/\/doi.org\/10.1182\/blood-2006-12-064527","journal-title":"Blood"},{"issue":"1","key":"9775_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.nec.2009.08.008","volume":"21","author":"E Albesiano","year":"2010","unstructured":"Albesiano E, Han JE, Lim M (2010) Mechanisms of local immunoresistance in glioma. Neurosurg Clin N Am 21(1):17\u201329. https:\/\/doi.org\/10.1016\/j.nec.2009.08.008","journal-title":"Neurosurg Clin N Am"},{"issue":"1-2","key":"9775_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11010-008-9877-3","volume":"319","author":"L Bavaresco","year":"2008","unstructured":"Bavaresco L, Bernardi A, Braganhol E, Cappellari AR, Rockenbach L, Farias PF, Wink MR, Delgado-Ca\u00f1edo A, Battastini AMO (2008) The role of ecto-5\u2032-nucleotidase\/CD73 in glioma cell line proliferation. Mol Cell Biochem 319(1-2):61\u201368. https:\/\/doi.org\/10.1007\/s11010-008-9877-3","journal-title":"Mol Cell Biochem"},{"key":"9775_CR11","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1007\/s12035-018-1240-4","volume":"56","author":"JH Azambuja","year":"2019","unstructured":"Azambuja JH, Gelsleichter NE, Beckenkamp LR, Iser IC, Fernandes MC, Figueir\u00f3 F, Battastini AMO, Scholl JN, de Oliveira FH, Spanevello RM, S\u00e9vigny J, Wink MR, Stefani MA, Teixeira HF, Braganhol E (2019) CD73 downregulation decreases in vitro and in vivo glioblastoma growth. Mol Neurobiol 56:3260\u20133279. https:\/\/doi.org\/10.1007\/s12035-018-1240-4","journal-title":"Mol Neurobiol"},{"issue":"9","key":"9775_CR12","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/neuonc\/not067","volume":"15","author":"S Xu","year":"2013","unstructured":"Xu S, Shao QQ, Sun JT, Yang N, Xie Q, Wang DH, Huang QB, Huang B, Wang XY, Li XG, Qu X (2013) Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas. Neuro Oncol 15(9):1160\u20131172. https:\/\/doi.org\/10.1093\/neuonc\/not067","journal-title":"Neuro Oncol"},{"key":"9775_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/1-4020-5688-5_1","volume":"42","author":"KD Rainsford","year":"2007","unstructured":"Rainsford KD (2007) Anti-inflammatory drugs in the 21st century. Subcell Biochem 42:3\u201327. https:\/\/doi.org\/10.1007\/1-4020-5688-5_1","journal-title":"Subcell Biochem"},{"issue":"3","key":"9775_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1590\/S0034-70942004000300017","volume":"54","author":"AW Carvalho","year":"2004","unstructured":"Carvalho AW, Carvalho RDS, Rios-Santos F (2004) Specific cyclooxygenase-2 inhibitor analgesics: therapeutic advances. Rev Bras Anestesiol 54(3):448\u2013464. https:\/\/doi.org\/10.1590\/S0034-70942004000300017","journal-title":"Rev Bras Anestesiol"},{"issue":"42","key":"9775_CR15","doi-asserted-by":"publisher","first-page":"68571","DOI":"10.18632\/oncotarget.11851","volume":"7","author":"T Williamson","year":"2016","unstructured":"Williamson T, Bai RY, Staedtke V et al (2016) Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model. Oncotarget 7(42):68571\u201368584. https:\/\/doi.org\/10.18632\/oncotarget.11851","journal-title":"Oncotarget"},{"issue":"3","key":"9775_CR16","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1124\/jpet.301.3.1126","volume":"301","author":"SJ Baek","year":"2002","unstructured":"Baek SJ (2002) Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene. J Pharmacol Exp Ther 301(3):1126\u20131131. https:\/\/doi.org\/10.1124\/jpet.301.3.1126","journal-title":"J Pharmacol Exp Ther"},{"issue":"1-2","key":"9775_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2007.04.058","volume":"569","author":"A Bernardi","year":"2007","unstructured":"Bernardi A, Bavaresco L, Wink MR, Jacques-Silva MC, Delgado-Ca\u00f1edo A, Lenz G, Battastini AMO (2007) Indomethacin stimulates activity and expression of ecto5\u2032-nucleotidase\/CD73 in glioma cell lines. Eur J Pharmacol 569(1-2):8\u201315. https:\/\/doi.org\/10.1016\/j.ejphar.2007.04.058","journal-title":"Eur J Pharmacol"},{"key":"9775_CR18","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3171\/2017.7.JNS17668","volume":"129","author":"MM Luedi","year":"2018","unstructured":"Luedi MM, Singh SK, Mosley JC, Hassan ISA, Hatami M, Gumin J, Andereggen L, Sulman EP, Lang FF, Stueber F, Fuller GN, Colen RR, Zinn PO (2018) Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. J Neurosurg 129:1446\u20131455. https:\/\/doi.org\/10.3171\/2017.7.JNS17668","journal-title":"J Neurosurg"},{"key":"9775_CR19","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.2967\/jnumed.117.207258","volume":"59","author":"CI McHugh","year":"2018","unstructured":"McHugh CI, Thipparthi MR, Lawhorn-Crews JM et al (2018) Using radiolabeled 3\u2032-deoxy-3\u2032-18F-fluorothymidine with PET to monitor the effect of dexamethasone on non-small cell lung cancer. J Nucl Med 59:1544\u20131550. https:\/\/doi.org\/10.2967\/jnumed.117.207258","journal-title":"J Nucl Med"},{"issue":"5","key":"9775_CR20","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1158\/1078-0432.ccr-0829-3","volume":"10","author":"H Wang","year":"2004","unstructured":"Wang H, Li M, Rinehart JJ, Zhang R (2004) Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy. Clin Cancer Res 10(5):1633\u20131644. https:\/\/doi.org\/10.1158\/1078-0432.ccr-0829-3","journal-title":"Clin Cancer Res"},{"issue":"4","key":"9775_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3892\/ijo.30.4.947","volume":"30","author":"H Wang","year":"2007","unstructured":"Wang H, Wang Y, Rayburn ER, Hill D, Rinehart J, Zhang R (2007) Dexamethasone as a chemosensitizer for breast cancer chemotherapy: potentiation of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics. Int J Oncol 30(4):947\u2013953. https:\/\/doi.org\/10.3892\/ijo.30.4.947","journal-title":"Int J Oncol"},{"issue":"1","key":"9775_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-007-9342-2","volume":"84","author":"L Bavaresco","year":"2007","unstructured":"Bavaresco L, Bernardi A, Braganhol E, Wink MR, Battastini AMO (2007) Dexamethasone inhibits proliferation and stimulates ecto-5\u2032- nucleotidase\/CD73 activity in C6 rat glioma cell line. J Neurooncol 84(1):1\u20138. https:\/\/doi.org\/10.1007\/s11060-007-9342-2","journal-title":"J Neurooncol"},{"key":"9775_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/PGPM.S167886","volume":"12","author":"S Jeibouei","year":"2019","unstructured":"Jeibouei S, Akbari ME, Kalbasi A, Aref A, Ajoudanian M, Rezvani A, Zali H (2019) Personalized medicine in breast cancer: pharmacogenomics approaches. Pharmgenomics Pers Med 12:59\u201373. https:\/\/doi.org\/10.2147\/PGPM.S167886","journal-title":"Pharmgenomics Pers Med"},{"key":"9775_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/PGPM.S62918","volume":"9","author":"JN Patel","year":"2016","unstructured":"Patel JN (2016) Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives. Pharmgenomics Pers Med 9:65\u201377. https:\/\/doi.org\/10.2147\/PGPM.S62918","journal-title":"Pharmgenomics Pers Med"},{"issue":"2","key":"9775_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11912-003-0098-3","volume":"5","author":"WT Purcell","year":"2003","unstructured":"Purcell WT, Ettinger DS (2003) Novel antifolate drugs. Curr Oncol Rep 5(2):114\u2013125. https:\/\/doi.org\/10.1007\/s11912-003-0098-3","journal-title":"Curr Oncol Rep"},{"issue":"31","key":"9775_CR26","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.2174\/1381612033453712","volume":"9","author":"JJ Mcguire","year":"2003","unstructured":"Mcguire JJ (2003) Anticancer antifolates: current status and future directions. Curr Pharm Des 9(31):2593\u20132613. https:\/\/doi.org\/10.2174\/1381612033453712","journal-title":"Curr Pharm Des"},{"issue":"2","key":"9775_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2165\/00003088-200342020-00003","volume":"42","author":"J Grim","year":"2003","unstructured":"Grim J, Chl\u00e1dek J, Mart\u00ednkov\u00e1 J (2003) Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases. Clin Pharmacokinet 42(2):139\u2013151. https:\/\/doi.org\/10.2165\/00003088-200342020-00003","journal-title":"Clin Pharmacokinet"},{"key":"9775_CR28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0065-2571(94)90025-6","volume":"34","author":"FM Huennekens","year":"1994","unstructured":"Huennekens FM (1994) The methotrexate story: a paradigm for development of cancer chemotherapeutic agents. Adv Enzyme Regul 34:397\u2013419. https:\/\/doi.org\/10.1016\/0065-2571(94)90025-6","journal-title":"Adv Enzyme Regul"},{"issue":"2","key":"9775_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11302-016-9505-8","volume":"12","author":"F Figueir\u00f3","year":"2016","unstructured":"Figueir\u00f3 F, de Oliveira CP, Bergamin LS, Rockenbach L, Mendes FB, Jandrey EHF, Moritz CEJ, Pettenuzzo LF, S\u00e9vigny J, Guterres SS, Pohlmann AR, Battastini AMO (2016) Methotrexate up-regulates ecto-5\u2032-nucleotidase\/CD73 and reduces the frequency of T lymphocytes in the glioblastoma microenvironment. Purinergic Signal 12(2):303\u2013312. https:\/\/doi.org\/10.1007\/s11302-016-9505-8","journal-title":"Purinergic Signal"},{"issue":"1-2","key":"9775_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11010-011-1141-6","volume":"362","author":"EB Scherer","year":"2012","unstructured":"Scherer EB, Savio LE, Vuaden FC, Ferreira AG, Bogo MR, Bonan CD, Wyse AT (2012) Chronic mild hyperhomocysteinemia alters ectonucleotidase activities and gene expression of ecto-5\u2032-nucleotidase\/CD73 in rat lymphocytes. Mol Cell Biochem 362(1-2):187\u2013194. https:\/\/doi.org\/10.1007\/s11010-011-1141-6","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"9775_CR31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1200\/JCO.2005.04.7522","volume":"24","author":"NA Butowski","year":"2006","unstructured":"Butowski NA, Sneed PK, Chang SM (2006) Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol 24(8):1273\u20131280. https:\/\/doi.org\/10.1200\/JCO.2005.04.7522","journal-title":"J Clin Oncol"},{"issue":"2","key":"9775_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97\u2013109. https:\/\/doi.org\/10.1007\/s00401-007-0243-4","journal-title":"Acta Neuropathol"},{"issue":"10145","key":"9775_CR33","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","volume":"392","author":"S Lapointe","year":"2018","unstructured":"Lapointe S, Perry A, Butowski NA (2018) Primary brain tumours in adults. Lancet 392(10145):432\u2013446. https:\/\/doi.org\/10.1016\/S0140-6736(18)30990-5","journal-title":"Lancet"},{"issue":"3","key":"9775_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/jnr.20485","volume":"81","author":"JJ Watters","year":"2005","unstructured":"Watters JJ, Schartner JM, Badie B (2005) Microglia function in brain tumors. J Neurosci Res 81(3):447\u2013455. https:\/\/doi.org\/10.1002\/jnr.20485","journal-title":"J Neurosci Res"},{"issue":"6","key":"9775_CR35","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1007\/s10637-013-0016-y","volume":"31","author":"EF da Silveira","year":"2013","unstructured":"da Silveira EF, Chassot JM, Teixeira FC, Azambuja JH, Debom G, Beira FT, del Pino FAB, Louren\u00e7o A, Horn AP, Cruz L, Spanevello RM, Braganhol E (2013) Ketoprofen-loaded polymeric nanocapsules selectively inhibit cancer cell growth in vitro and in preclinical model of glioblastoma multiforme. Invest New Drugs 31(6):1424\u20131435. https:\/\/doi.org\/10.1007\/s10637-013-0016-y","journal-title":"Invest New Drugs"},{"issue":"4-5","key":"9775_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s002100000309","volume":"362","author":"H Zimmermann","year":"2000","unstructured":"Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362(4-5):299\u2013309. https:\/\/doi.org\/. https:\/\/doi.org\/10.1007\/s002100000309","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"34","key":"9775_CR37","doi-asserted-by":"publisher","first-page":"57327","DOI":"10.18632\/oncotarget.16905","volume":"8","author":"R Wang","year":"2017","unstructured":"Wang R, Zhang Y, Lin X et al (2017) Prognositic value of CD73-adenosinergic pathway in solid tumor: a meta-analysis and systematic review. Oncotarget 8(34):57327\u201357336. https:\/\/doi.org\/10.18632\/oncotarget.16905","journal-title":"Oncotarget"},{"issue":"10","key":"9775_CR38","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1166\/jbn.2015.2125","volume":"11","author":"F Figueir\u00f3","year":"2015","unstructured":"Figueir\u00f3 F, de Oliveira CP, Rockenbach L, Mendes FB, Bergamin LS, Jandrey EHF, Edelweiss MI, Guterres SS, Pohlmann AR, Battastini AMO (2015) Pharmacological improvement and preclinical evaluation of methotrexate-loaded lipid-core nanocapsules in a glioblastoma model. J Biomed Nanotechnol 11(10):1808\u20131818. https:\/\/doi.org\/10.1166\/jbn.2015.2125","journal-title":"J Biomed Nanotechnol"},{"issue":"1","key":"9775_CR39","doi-asserted-by":"publisher","first-page":"1744946","DOI":"10.1080\/2162402X.2020.1744946T","volume":"9","author":"I Shevchenko","year":"2020","unstructured":"Shevchenko I, Mathes A, Groth C, Karakhanova S, M\u00fcller V, Utikal J, Werner J, Bazhin AV, Umansky V (2020) Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses. OncoImmunology 9(1):1744946. https:\/\/doi.org\/10.1080\/2162402X.2020.1744946T","journal-title":"OncoImmunology"},{"issue":"11","key":"9775_CR40","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.bcp.2013.08.063","volume":"86","author":"C Wang","year":"2013","unstructured":"Wang C, Lin W, Playa H, Sun S, Cameron K, Buolamwini JK (2013) Dipyridamole analogs as pharmacological inhibitors of equilibrative nucleoside transporters. Identification of novel potent and selective inhibitors of the 55 adenosine transporter function of human equilibrative nucleoside transporter 4 (hENT4). Biochem Pharmacol 86(11):1531\u20131540. https:\/\/doi.org\/10.1016\/j.bcp.2013.08.063","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"9775_CR41","first-page":"495","volume":"296","author":"DL Boyle","year":"2001","unstructured":"Boyle DL, Kowaluk EA, Jarvis MF, Lee CH, Bhagwat SS, Williams M, Firestein GS (2001) Anti-inflammatory effects of ABT-702, a novel nonnucleoside adenosine kinase inhibitor, in rat adjuvant arthritis. J Pharmacol Exp Ther 296(2):495\u2013500","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"9775_CR42","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1189\/jlb.0609385","volume":"86","author":"G Solinas","year":"2009","unstructured":"Solinas G, Germano G, Mantovani A, Allavena P (2009 Nov) (2009) Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86(5):1065\u20131073. https:\/\/doi.org\/10.1189\/jlb.0609385","journal-title":"J Leukoc Biol"},{"issue":"7007","key":"9775_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/431405a","volume":"431","author":"F Balkwill","year":"2004","unstructured":"Balkwill F, Coussens LM (2004) Cancer: an inflammatory link. Nature 431(7007):405\u2013406. https:\/\/doi.org\/10.1038\/431405a","journal-title":"Nature"},{"key":"9775_CR44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4137\/CMO.S7685","volume":"5","author":"M Nieto-Sampedro","year":"2011","unstructured":"Nieto-Sampedro M, Valle-Argos B, G\u00f3mez-Nicola D, Fern\u00e1ndez-Mayoralas A, Nieto-D\u00edaz M (2011) Inhibitors of glioma growth that reveal the tumour to the immune system. Clin Med Insights Oncol 5:265\u2013314. https:\/\/doi.org\/10.4137\/CMO.S7685","journal-title":"Clin Med Insights Oncol"},{"issue":"5","key":"9775_CR45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMra0708126","volume":"359","author":"PY Wen","year":"2008","unstructured":"Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492\u2013507. https:\/\/doi.org\/10.1056\/NEJMra0708126","journal-title":"N Engl J Med"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-021-09775-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-021-09775-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-021-09775-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T10:29:32Z","timestamp":1622024972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-021-09775-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,20]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["9775"],"URL":"https:\/\/doi.org\/10.1007\/s11302-021-09775-w","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,20]]},"assertion":[{"value":"3 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Daniela Vasconcelos Lopes declares no competing interests.Amanda de Fraga Dias declares no competing interests.Luiz Fernando Lopes Silva declares no competing interests.Juliete Nathali Scholl declares no competing interests.Jean S\u00e9vigny declares no competing interests.Ana Maria Oliveira Battastini declares no competing interests.Fabr\u00edcio Figueir\u00f3 declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}